PTX 0.00% 4.2¢ prescient therapeutics limited

Cornhulio, following link on current proceedings. December 7,...

  1. 1,656 Posts.
    lightbulb Created with Sketch. 198
    Cornhulio, following link on current proceedings.
    December 7, 2016 - UC Davis to Conduct Phase 2 Trial of the Combination of TG4010 with Opdivo® (nivolumab) for 2nd Line Treatment of Metastatic Non-Small Cell Lung Cancer (NSCLC) / The trial will be supported by Transgene and Bristol-Myers Squibb http://www.transgene.fr/wp-content/...7-Collaboration_UC_Davis_Transgene-BMS_EN.pdf
 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
0.000(0.00%)
Mkt cap ! $33.82M
Open High Low Value Volume
4.2¢ 4.2¢ 4.2¢ $17.55K 418.0K

Buyers (Bids)

No. Vol. Price($)
3 80471 4.2¢
 

Sellers (Offers)

Price($) Vol. No.
4.4¢ 225514 2
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.